Silo Pharma, Inc.

Filed a patent for "use of cns-homing targeting peptides for treating neurological disorders" on Mon, January 30, 2023

Filed a patent for "use of cns-homing targeting peptides for treating neurological disorders" on Thu, August 1, 2024

Filed a patent for "central nervous system delivery of psilocybin" on Thu, August 3, 2023

Filed a patent for "central nervous system delivery of nonsteroidal anti-inflammatory drugs" on Thu, August 10, 2023

Filed a patent for "central nervous system delivery of nonsteroidal anti-inflammatory drugs and psilocybin" on Thu, November 2, 2023

Filed a patent for "use of psilocybin in cancer treatment" on Thu, February 22, 2024